growth hormone therapy

Temple Syndrome: Unveiling a Hidden Multi-System Growth Disorder and Introducing a New Diagnostic Score

By MedXY 08/11/2026

Temple syndrome is an under-recognised imprinting disorder with complex endocrine and growth abnormalities. This large-cohort study clarifies its phenotype, highlights growth hormone therapy benefits, and proposes a novel clinical scoring system to enable earlier diagnosis and tailored management.

Diabetes & Endocrinology news Pediatrics

Once-Weekly Somapacitan: A New Frontier in Growth Hormone Therapy for Girls with Turner Syndrome

By MedXY 08/03/2026

A phase 3 trial demonstrates that once-weekly somapacitan is non-inferior to daily growth hormone injections in promoting linear growth in girls with Turner syndrome, offering a promising alternative with comparable safety and efficacy profiles.

Diabetes & Endocrinology news Pediatrics

Children Born SGA Receiving Growth Hormone Have Similarly Impaired Glucose-Insulin Metabolism as Children With Obesity

By MedXY 05/19/2026

Children born SGA receiving growth hormone showed insulin resistance and prediabetes rates similar to obesity, suggesting the need for careful glucose monitoring during and after treatment.